CEO Of China's Leading Vaccine Producer Reveals Latest Vaccine Scandal Has Triggered A Sector-wide Boycott, Throwing Firm Into The Red
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The chief executive officer of Sinovac Biotech, China's leading vaccine developer, told investors this week that the country's latest vaccine scandal had poisoned public perceptions so deeply that many citizens are boycotting the entire sector
You may also be interested in...
China's Leading Vaccine Developer Sees Sales Slashed Due To Popular Backlash Against Series Of Scandals
BEIJING - Pummeled by a de facto nationwide public boycott of domestically produced inoculations following a series of faulty vaccine releases by other firms that have in some cases led to fatalities, China's leading vaccine maker, Sinovac Biotech, reported sales revenues for 2010 that were just half of original projections
China's Leading Vaccine Developer Sees Sales Slashed Due To Popular Backlash Against Series Of Scandals
BEIJING - Pummeled by a de facto nationwide public boycott of domestically produced inoculations following a series of faulty vaccine releases by other firms that have in some cases led to fatalities, China's leading vaccine maker, Sinovac Biotech, reported sales revenues for 2010 that were just half of original projections
China's Sinovac Sees Profits Plummet In Wake Of Public Fears Following Vaccine Scandals By Other Producers
BEIJING - China's leading vaccine developer, Sinovac Biotech, posted a steep fall in profits for the second quarter, and revealed that the World Health Organization is working with Chinese regulators on monitoring good manufacturing practice standards following a series of scandals that have hurt the entire sector